UPDATED April 19, 2012: Tekturna (aliskiren) tablets and Aliskiren-Based Products Information Center
Please see important information about Tekturna and aliskiren-based products:
- Read the Company Statement
- Read the Dear Healthcare Provider Letter
- Download the PDF for Frequently Asked Questions
View full Prescribing Information, including IMPORTANT WARNING, for Tekturna
View full Prescribing Information, including IMPORTANT WARNING, for Tekturna HCT
View full Prescribing Information, including IMPORTANT WARNING, for Valturna
View full Prescribing Information, including IMPORTANT WARNING, for Amturnide
View full Prescribing Information, including IMPORTANT WARNING, for Tekamlo
View full Prescribing Information, including IMPORTANT WARNING, for Tekturna HCT
View full Prescribing Information, including IMPORTANT WARNING, for Valturna
View full Prescribing Information, including IMPORTANT WARNING, for Amturnide
View full Prescribing Information, including IMPORTANT WARNING, for Tekamlo
Our Products
For Healthcare Professionals
HELPING THOSE IN NEED
At Novartis Pharmaceuticals Corporation, we believe that all Americans deserve access to quality health care. Find out about a resource that allows you to access programs that may help you pay for your Novartis medicines.
Find out more at Patient Assistance Now.comGRANTS
Novartis Pharmaceuticals Corporation supports a range of grants to support education, advocacy and outreach efforts. Call 1-888-NOW-Nova.